SCHEDULE: Hayfin Group Discloses 6.2% Stake in Heartflow, Inc.
Beneficial Ownership Report (Schedule 13G)
Hayfin Management Holdings Limited and its affiliates have reported a 6.2% beneficial ownership stake in Heartflow, Inc.'s Class A Common Stock.
Summary
- Hayfin Management Holdings Limited, along with its affiliated entities, collectively reported beneficial ownership of 5,283,264 shares of Heartflow, Inc. Class A Common Stock as of September 30, 2025.
- This aggregate ownership represents 6.2% of Heartflow, Inc.'s Class A Common Stock outstanding, based on 85,158,719 shares outstanding as of October 31, 2025.
- The reported beneficial ownership includes 3,635,597 shares indirectly held and 1,647,667 shares subject to warrants indirectly held by Hayfin Management Holdings Limited.
- Subsequent to the September 30, 2025 event date, specifically on October 27, 2025, warrants for 1,647,667 shares were exercised on a net-exercise basis, resulting in the issuance of 1,646,317 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership and warrant exercise, which is neutral in sentiment. The increased institutional ownership could be seen as a positive, but the filing itself does not convey explicit positive or negative sentiment.
Positives
- Increased institutional ownership by a significant investment group, Hayfin, which may signal confidence in Heartflow, Inc.'s long-term prospects.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- The filing details a group of related Hayfin entities (e.g., Hayfin Management Holdings Limited, Hayfin Heartflow UK Limited, Hayfin Tourmaline LuxCo S.a.r.l., and various funds/LPs) that collectively report beneficial ownership. Hayfin Management Holdings Limited is identified as the sole member or sole shareholder of the general partners for many of these entities, establishing a clear related-party structure for their aggregated ownership.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by the Hayfin group could be viewed positively, indicating investor confidence and potentially providing a more stable shareholder base.
Key Dates
| Date | Description |
|---|---|
| 2025-09-30 | Date of event requiring the filing of this statement (beneficial ownership calculation date). |
| 2025-10-27 | Date when warrants were exercised on a net-exercise basis, resulting in the issuance of common stock. |
| 2025-10-31 | Date as of which 85,158,719 shares of Class A Common Stock were reported outstanding in Heartflow, Inc.'s Quarterly Report on Form 10-Q. |
| 2025-11-12 | Date Heartflow, Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, was filed with the SEC. |
| 2025-11-13 | Date of signing and filing of this Schedule 13G. |
Keywords
Heartflow Inc, Hayfin Management Holdings, Beneficial Ownership, Schedule 13G, Class A Common Stock, Warrant Exercise, Institutional Investor, Healthcare Technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.